INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Medical Monitoring

Comprehensive medical monitoring services for dermatology and rheumatology clinical trials. We provide medical and scientific support that ensures subject safety and data integrity.

Medical Monitoring Team Members

0 +
 Years of Experience
1 +
Clinical Trials
475 +

How Our Medical Monitoring Team Works

From high-level medical oversight to regional site medical support, Indero’s medical monitors are all in with your clinical trial. Here’s what our medical monitoring team is responsible for:

Medical Oversight

  • Medical monitoring plan development
  • Attend safety kickoff, investigator, and Independent Data Monitoring Committee (IDMC) meetings
  • Provide medical oversight during the trial’s business hours, including monitoring protocol inclusions and exclusions, medical conditions, and prohibited medications
  • Be on-call for urgent trial-related safety issues outside of office hours
  • Meet and communicate with project team members on an ongoing basis, including working with a subject decision log to escalate potential issues
  • Review safety data and coding on a monthly basis, including demographics, medical history, concomitant medications, physical examination, laboratory results, vital signs, ECG results, adverse events (AE), serious adverse events (SAE), and protocol deviations

Regional Site Medical Support

  • Serve as a point of contact for sites for questions about eligibility, concomitant medications, safety protocol deviations, and ongoing protocol-related medical issues
  • Provide day-to-day support, from Site Initiation Visit (SIV) to Last Subject Last Visit (LSLV)
  • Provide 24/7 support for urgent trial-related safety issues
  • Escalate issues identified during site contact
  • React to alerts for safety assessments and follow up with sites on subjects’ safety alerts

Safety Data Review with Spotfire

  • Platform used to manage subject safety data in larger studies
  • Linked to Electronic Data Capture (EDC) system
  • New data automatically uploads overnight
  • Allows for parallel review with sponsor
  • Quickly identify outliers and trends in datasets
  • Add comments or queries directly

Partner with Indero’s Medical Monitoring Team

Indero is a dual-focus CRO for dermatology and rheumatology clinical trials that ensures subject safety and data integrity through our expert medical monitoring services. Tell us about your clinical trial needs.

Let’s talk

Medical Monitoring Services That Accelerate Studies

Scientific discipline. Operational efficiency. Clinical development expertise. Our medical monitoring services provide the rigorous foundation, quality data, and expertise dermatology and rheumatology studies need to ensure effective execution and on-time delivery.

ABOUT INDERO

“Thanks to Indero’s adaptive approach, we sailed through our trial with ease! (
) Indero has proven to be a reliable and invaluable partner, and we look forward to continuing our successful collaboration with them.”

Sara Penchev

Director of Clinical Operations

Wherever You’re Going,
We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Talk to us

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >